ABVC BioPharma, Inc.
ABVC
$1.33
$0.021.53%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 56.21% | -185.83% | 44.77% | -168.02% | -15.10% |
| Total Depreciation and Amortization | -56.92% | 122.92% | 18.81% | -29.06% | 193.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.52% | 70.31% | -28.68% | 693.83% | -54.83% |
| Change in Net Operating Assets | -61.89% | 54.55% | 56.76% | -1,795.85% | 93.73% |
| Cash from Operations | 36.98% | -964.52% | 85.09% | -65.65% | 23.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -93.55% | 157.35% | -91.26% | -- | -- |
| Cash from Investing | -93.55% | 157.35% | -91.26% | -- | -- |
| Total Debt Issued | -- | 386.67% | 1,566.67% | -- | -- |
| Total Debt Repaid | -508.74% | 67.62% | -353.04% | -152.90% | 83.45% |
| Issuance of Common Stock | -20.20% | -59.93% | -35.35% | 395.21% | 439.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -200.00% | -92.28% |
| Cash from Financing | -129.77% | 1.51% | -41.24% | 349.46% | 27.70% |
| Foreign Exchange rate Adjustments | -78.69% | -76.45% | 202.37% | -844.12% | 94.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -350.83% | 312.72% | -170.20% | 404.03% | -210.97% |